NZ203117A - Nasally applied pharmaceutical compositions - Google Patents

Nasally applied pharmaceutical compositions

Info

Publication number
NZ203117A
NZ203117A NZ203117A NZ20311783A NZ203117A NZ 203117 A NZ203117 A NZ 203117A NZ 203117 A NZ203117 A NZ 203117A NZ 20311783 A NZ20311783 A NZ 20311783A NZ 203117 A NZ203117 A NZ 203117A
Authority
NZ
New Zealand
Prior art keywords
composition according
agent
nasal
composition
active agent
Prior art date
Application number
NZ203117A
Other languages
English (en)
Inventor
J-R Kiechel
F Aczat-Mispelter
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ203117A publication Critical patent/NZ203117A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NZ203117A 1982-02-01 1983-01-28 Nasally applied pharmaceutical compositions NZ203117A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (1)

Publication Number Publication Date
NZ203117A true NZ203117A (en) 1986-12-05

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ203117A NZ203117A (en) 1982-02-01 1983-01-28 Nasally applied pharmaceutical compositions

Country Status (27)

Country Link
JP (1) JPS58134017A (en:Method)
AT (1) AT385656B (en:Method)
AU (1) AU565613B2 (en:Method)
BE (1) BE895750A (en:Method)
CA (1) CA1197783A (en:Method)
CH (1) CH653555A5 (en:Method)
DE (1) DE3302949A1 (en:Method)
DK (1) DK164771C (en:Method)
ES (1) ES519450A0 (en:Method)
FI (1) FI81258C (en:Method)
FR (1) FR2539994B1 (en:Method)
GR (1) GR81320B (en:Method)
HK (1) HK59989A (en:Method)
HU (1) HU191512B (en:Method)
IE (1) IE54532B1 (en:Method)
IL (1) IL67822A (en:Method)
IT (1) IT1197558B (en:Method)
KE (1) KE3888A (en:Method)
LU (1) LU84613A1 (en:Method)
MY (1) MY8700766A (en:Method)
NL (1) NL192325C (en:Method)
NZ (1) NZ203117A (en:Method)
PH (1) PH22198A (en:Method)
PT (1) PT76166B (en:Method)
SE (1) SE454402B (en:Method)
SG (1) SG34389G (en:Method)
ZA (1) ZA83673B (en:Method)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
JP7317020B2 (ja) * 2018-01-05 2023-07-28 インペル ファーマシューティカルズ インコーポレイテッド 精密嗅覚デバイスによるジヒドロエルゴタミンの鼻腔内送達

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
FR2387035A1 (fr) * 1977-04-12 1978-11-10 Cassenne Lab Sa Nouveau medicament destine notamment au traitement des troubles fonctionnels cerebraux
DE2831728C2 (de) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Arzneimittel zur Behandlung von Kopfschmerzen

Also Published As

Publication number Publication date
IL67822A (en) 1988-02-29
AU1085083A (en) 1983-08-11
MY8700766A (en) 1987-12-31
IT8347646A0 (it) 1983-02-01
NL192325B (nl) 1997-02-03
IT1197558B (it) 1988-12-06
FR2539994B1 (fr) 1986-10-10
ES8502865A1 (es) 1985-02-01
IL67822A0 (en) 1983-06-15
IE830187L (en) 1983-08-01
ES519450A0 (es) 1985-02-01
PT76166A (en) 1983-02-01
IT8347646A1 (it) 1984-08-01
GR81320B (en:Method) 1984-12-11
SE8300495L (sv) 1983-08-02
SE8300495D0 (sv) 1983-01-31
IE54532B1 (en) 1989-11-08
BE895750A (fr) 1983-08-01
FI81258B (fi) 1990-06-29
SG34389G (en) 1989-09-22
ATA30383A (de) 1987-10-15
NL192325C (nl) 1997-06-04
KE3888A (en) 1989-09-01
CA1197783A (en) 1985-12-10
FI81258C (fi) 1990-10-10
DK164771B (da) 1992-08-17
JPH0253406B2 (en:Method) 1990-11-16
NL8300325A (nl) 1983-09-01
FR2539994A1 (fr) 1984-08-03
HK59989A (en) 1989-08-04
PT76166B (en) 1986-02-04
ZA83673B (en) 1984-09-26
HU191512B (en) 1987-02-27
FI830245A0 (fi) 1983-01-25
DK38183A (da) 1983-08-02
CH653555A5 (de) 1986-01-15
SE454402B (sv) 1988-05-02
DK164771C (da) 1992-12-28
AU565613B2 (en) 1987-09-24
AT385656B (de) 1988-05-10
PH22198A (en) 1988-06-28
JPS58134017A (ja) 1983-08-10
FI830245L (fi) 1983-08-02
DE3302949C2 (en:Method) 1992-05-21
LU84613A1 (fr) 1983-09-08
DE3302949A1 (de) 1983-08-11
DK38183D0 (da) 1983-01-31

Similar Documents

Publication Publication Date Title
US5169849A (en) Nasal pharmaceutical compositions
EP0760649B1 (en) Fluticasone propionate formulations
RU2421209C2 (ru) Фармацевтические композиции, содержащие циклоспорин
US4556557A (en) Method and composition for combating snoring, and the use of surface active substances for the preparation of said composition
JP3830158B2 (ja) 禁煙補助組成物
PT999841E (pt) Composicoes farmaceuticas contendo hemissulfato de eletriptano
WO1995017164A1 (en) A pharmaceutical composition for the intranasal administration of hydroxocobalamin
CA2581209A1 (en) Targeted delivery of lidocaine and other local anesthetics and a method for treatment of cough and tussive attacks
US4885305A (en) Nasal compositions
WO1996000071A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with a liquid nasal composition containing nicotine and caffeine or xanthine
SK12682003A3 (sk) Prípravky obsahujúce imidazotriazinón na nazálnu aplikáciu
JPH02196716A (ja) 薬学的溶液
GB2114001A (en) Nasal pharmaceutical compositions
CA1197783A (en) Nasal pharmaceutical compositions
ES2398576T3 (es) Tratamiento agudo de la fobia social con un esteroide androsta-4,16-dien-3-ol
CN111787954A (zh) 使用莫美他松和奥洛他定的组合治疗儿科受试者的过敏性鼻炎
WO2022109458A1 (en) Imatinib formulations, manufacture, and uses thereof
HK1093017A1 (en) Inhalable formulations for treating pulmonary hypertension and methods of using same
HK1093017B (en) Inhalable formulations for treating pulmonary hypertension and methods of using same